Law360, New York (July 09, 2010, 5:58 PM ET) -- The U.S. Court of Appeals for the Second Circuit's July 6 decision finding that drug industry representatives at Novartis Pharmaceuticals Corp. were not exempt from the nation's overtime laws muddies the legal landscape and leaves the contentious issue ripe for a definitive ruling, employment lawyers say.
Although the Second Circuit opinion — which found that drug representatives should not be subject to either the outside sales or administrative exemptions of the Fair Labor Standards Act — is the most decisive appeals court ruling to date, it...
2nd Circ. Novartis Ruling Muddies Sales Rep OT Issue
To view the full article, take a free trial now.
